1.Gölz L, Memmert S, Rath-Deschner B, Jäger A, Appel T, Baumgarten G, Götz W, Frede S: Hypoxia and P. gingivalis synergistically induce HIF–1 and NF-κB activation in PDL cells and periodontal diseases. Mediators of inflammation 2015, 2015:438085–438085.
2.Györfi A, Fazekas Á, Rosivall L: Neurogenic inflammation and the oral mucosa. Journal of Clinical Periodontology 1992, 19(10):731–736.
3.Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R: Neuropeptide substance P and the immune response. Cell Mol Life Sci 2016, 73(22):4249–4264.
4.Suvas S: Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis. J Immunol 2017, 199(5):1543–1552.
5.de Avila ED, de Molon RS, de Godoi Goncalves DA, Camparis CM: Relationship between levels of neuropeptide Substance P in periodontal disease and chronic pain: a literature review. Journal of investigative and clinical dentistry 2014, 5(2):91–97.
6.Bull HA, Hothersall J, Chowdhury N, Cohen J, Dowd PM: Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. The Journal of investigative dermatology 1996, 106(4):655–660.
7.Um J, Jung N, Chin S, Cho Y, Choi S, Park KS: Substance P enhances EPC mobilization for accelerated wound healing. 2016, 24(2):402–410.
8.Linden GJ, McKinnell J, Shaw C, Lundy FT: Substance P and neurokinin A in gingival crevicular fluid in periodontal health and disease. Journal of clinical periodontology 1997, 24(11):799–803.
9.Pradeep AR, Raj S, Aruna G, Chowdhry S: Gingival crevicular fluid and plasma levels of neuropeptide Substance-P in periodontal health, disease and after nonsurgical therapy. Journal of Periodontal Research 2009, 44(2):232–237.
10.Biddlestone J, Bandarra D, Rocha S: The role of hypoxia in inflammatory disease (review). International journal of molecular medicine 2015, 35(4):859–869.
11.Colgan SP, Campbell EL, Kominsky DJ: Hypoxia and Mucosal Inflammation. Annu Rev Pathol 2016, 11:77–100.
12.Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V et al: HIF–1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112(5):645–657.
13.Feng N, Chen H, Fu S, Bian Z, Lin X, Yang L, Gao Y, Fang J, Ge Z: HIF–1α and HIF–2α induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide. Scientific reports 2016, 6:27280–27280.
14.Kim Y, Nam HJ, Lee J, Park DY, Kim C, Yu YS, Kim D, Park SW, Bhin J, Hwang D et al: Methylation-dependent regulation of HIF–1α stability restricts retinal and tumour angiogenesis. Nat Commun 2016, 7:10347–10347.
15.Yu X-J, Xiao C-J, Du Y-M, Liu S, Du Y, Li S: Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament cells in vitro. International journal of clinical and experimental pathology 2015, 8(10):12929–12935.
16.Yu X, Gong Z, Lin Q, Wang W, Liu S, Li S: Denervation effectively aggravates rat experimental periodontitis. Journal of Periodontal Research 2017, 52(6):1011–1020.
17.Gyorfi A, Fazekas A, Rosivall L: Neurogenic inflammation and the oral mucosa. Journal of clinical periodontology 1992, 19(10):731–736.
18.Azuma H, Kido J, Ikedo D, Kataoka M, Nagata T: Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J Periodontol 2004, 75(7):974–981.
19.Hosokawa Y, Hosokawa I, Shindo S, Ozaki K, Nakae H, Matsuo T: Tumor necrosis factor–like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β–stimulated human gingival fibroblasts. Human Immunology 2012, 73(5):470–473.
20.Niedermair T, Schirner S, Seebroker R, Straub RH: Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts. 2018, 8(1):9199.
21.Goto T, Yamaza T, Kido MA, Tanaka T: Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin–1 receptor in bone. Cell and tissue research 1998, 293(1):87–93.
22.Mori T, Ogata T, Okumura H, Shibata T, Nakamura Y, Kataoka K: Substance P regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochemical and biophysical research communications 1999, 262(2):418–422.
23.Belibasakis GN, Bostanci N: The RANKL-OPG system in clinical periodontology. Journal of Clinical Periodontology 2012, 39(3):239–248.
24.Lee HJ, Jeong GS, Pi SH, Lee SI, Bae WJ, Kim SJ, Lee SK, Kim EC: Heme oxygenase–1 protects human periodontal ligament cells against substance P-induced RANKL expression. Journal of Periodontal Research 2010, 45(3):367–374.
25.Semenza GL: Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annual review of pathology 2014, 9:47–71.
26.Blouin CC, Page EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004, 103(3):1124–1130.
27.Taylor CT, Colgan SP: Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol 2017, 17(12):774–785.
28.McGarry T, Biniecka M, Veale DJ, Fearon U: Hypoxia, oxidative stress and inflammation. Free Radical Biology and Medicine 2018, 125:15–24.
29.Hirai K, Furusho H, Hirota K, Sasaki H: Activation of hypoxia-inducible factor 1 attenuates periapical inflammation and bone loss. Int J Oral Sci 2018, 10(2):12–12.
30.Palazon A, Goldrath AW, Nizet V, Johnson RS: HIF transcription factors, inflammation, and immunity. Immunity 2014, 41(4):518–528.
31.Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH et al: Succinate is an inflammatory signal that induces IL–1beta through HIF–1alpha. Nature 2013, 496(7444):238–242.
32.Thompson AA, Binham J, Plant T, Whyte MK, Walmsley SR: Hypoxia, the HIF pathway and neutrophilic inflammatory responses. Biological chemistry 2013, 394(4):471–477.
33.Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A, Condliffe AM, Cowburn AS, Johnson N et al: Hypoxia-induced neutrophil survival is mediated by HIF–1alpha-dependent NF-kappaB activity. J Exp Med 2005, 201(1):105–115.